Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05290233 · ClinicalTrials.gov registry record · NA

Time Restricted Eating Plus Exercise for Weight Management

A NA study, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
36
Enrollment target

NCT05290233 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 36 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05290233, a NA study, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

Time restricted eating (TRE) is currently the most popular form of intermittent fasting which involves confining the eating window to 8-10 hours (h) and fasting for the remaining hours of the day. TRE is unique in that during the eating window, individuals are not required to count calories or monitor food intake in any way, resulting in high adherence. Accumulating evidence suggests that TRE produces a natural energy deficit of \~350-500 kcal/d. Physical activity in combination with a healthy diet pattern is recommended for older adults. While aerobic type exercise is the most commonly recommended, retention of lean mass via resistance training, especially in older adults, may be more effective at improving mobility, neurological and psychological function, executive and cognitive functioning, and processing speed. TRE combined with physical activity has not been examined in older adults or in people with overweight or obesity. This study holds the potential to 1) decrease body weight 2) improve lean mass 3) improve insulin sensitivity, and 4) improve attention, executive functioning, and processing speed in older adults. The aims of this study will examine the effect of TRE combined with either resistance training or aerobic training on body weight, body composition, metabolic disease risk, and cognition in adults over age 50. It is hypothesized that the TRE combined with resistance training group will see the most significant improvements in body composition, insulin sensitivity and cognition due to lean mass accretion.

Interventions

  • BEHAVIORAL TRE + Exercise

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2023-09-21
Est. Completion 2024-07-18
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT05290233

The ClinicalTrials.gov registry entry for NCT05290233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which TRE + Exercise is the first listed.

NCT05290233 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05290233 about?

NCT05290233 is a clinical study titled "Time Restricted Eating Plus Exercise for Weight Management". Time restricted eating (TRE) is currently the most popular form of intermittent fasting which involves confining the eating window to 8-10 hours (h) and fasting for the remaining hours of the day. TRE is unique in that during the eating window, individuals are not required to count calories or monit...

What is the current status of trial NCT05290233?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2023-09-21. Estimated completion is 2024-07-18.

What interventions are being tested in trial NCT05290233?

The interventions under investigation include: TRE + Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05290233?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.